KMI Diagnostics, Inc. – Trademark Portfolio

Entity Type: 03

KMI Diagnostics, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include KMI DIAGNOSTICS. The owner is based in Minneapolis, MN.

8201 Central Avenue NE, Suite P

Minneapolis, MN 55432

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

KMI Diagnostics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does KMI Diagnostics, Inc. have?

KMI Diagnostics, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does KMI Diagnostics, Inc. file in?

KMI Diagnostics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.

What are KMI Diagnostics, Inc.'s most well-known trademarks?

KMI Diagnostics, Inc.'s registered trademark portfolio includes well-known marks such as KMI DIAGNOSTICS. These are among 1 currently registered trademark in the portfolio.

What is KMI Diagnostics, Inc.'s trademark registration success rate?

KMI Diagnostics, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.